amantadine has been researched along with 4-aminopyridine in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Broadley, KJ; Rothaul, AL; Urquhart, RA | 1 |
| Northover, BJ | 1 |
| Krisztin-Péva, B; Mihály, A; Szakács, R; Weiczner, R; Zádor, E; Zádor, Z | 1 |
| Debouverie, M; Pittion, S | 1 |
| Boërio, D; Créange, A; Hogrel, JY; Lefaucheur, JP | 1 |
| Deng, XY; Wang, L; Yang, TT; Yu, G | 1 |
| Colombo, B; Filippi, M; Martinelli, V; Rocca, MA; Valsasina, P | 1 |
| Cameron, MH; Cohen, JA; Elfont, R; Goldman, MD; Goodman, AD; Johnson, R; Llorens, L; Miller, AE; Patni, R; Rollins, A | 1 |
2 review(s) available for amantadine and 4-aminopyridine
| Article | Year |
|---|---|
[Pathophysiology and treatment of fatigue in multiple sclerosis].
Topics: 4-Aminopyridine; Acute Disease; Amantadine; Amifampridine; Asthenia; Benzhydryl Compounds; Central Nervous System; Chronic Disease; Fatigue; Humans; Mental Fatigue; Modafinil; Multiple Sclerosis; Pemoline; Peripheral Nervous System; Physical Exertion; Severity of Illness Index; Surveys and Questionnaires | 2006 |
Pharmacological treatments for fatigue in patients with multiple sclerosis: A systematic review and meta-analysis.
Topics: 4-Aminopyridine; Amantadine; Central Nervous System Stimulants; Dopamine Agents; Drug Therapy; Fatigue; Humans; Multiple Sclerosis; Pemoline | 2017 |
2 trial(s) available for amantadine and 4-aminopyridine
| Article | Year |
|---|---|
Cortico-subcortical functional connectivity modifications in fatigued multiple sclerosis patients treated with fampridine and amantadine.
Topics: 4-Aminopyridine; Amantadine; Brain; Fatigue; Humans; Magnetic Resonance Imaging; Multiple Sclerosis | 2021 |
A Phase 3, double-blind, placebo-controlled efficacy and safety study of ADS-5102 (Amantadine) extended-release capsules in people with multiple sclerosis and walking impairment.
Topics: 4-Aminopyridine; Adult; Amantadine; Delayed-Action Preparations; Double-Blind Method; Humans; Multiple Sclerosis; Walking | 2022 |
4 other study(ies) available for amantadine and 4-aminopyridine
| Article | Year |
|---|---|
86Rubidium efflux and negative inotropy induced by P1- and muscarinic-receptor agonists in guinea-pig left atria. Effects of potassium channel blockers.
Topics: 4-Aminopyridine; Adenosine; Amantadine; Animals; Carbachol; Drug Interactions; Guinea Pigs; Half-Life; Heart Atria; Male; Parasympathomimetics; Phenylisopropyladenosine; Potassium; Potassium Channels; Rubidium Radioisotopes; Theophylline | 1991 |
Effect of pre-treating rat atria with potassium channel blocking drugs on the electrical and mechanical responses to phenylephrine.
Topics: 4-Aminopyridine; Action Potentials; Adenosine; Amantadine; Amifampridine; Animals; Cesium; Chlorides; Heart Atria; In Vitro Techniques; Isoproterenol; Phenylephrine; Potassium Channel Blockers; Rats; Sparteine; Systole | 1994 |
Non-competitive NMDA receptor antagonists moderate seizure-induced c-fos expression in the rat cerebral cortex.
Topics: 4-Aminopyridine; Amantadine; Animals; Behavior, Animal; Cerebral Cortex; Dizocilpine Maleate; Dopamine Agents; Epilepsy; Excitatory Amino Acid Antagonists; Gene Expression; Hippocampus; Immunohistochemistry; Ketamine; Male; Potassium Channel Blockers; Proto-Oncogene Proteins c-fos; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; RNA, Messenger | 2003 |
[Fatigue and episodic exhaustion as a feature of multiple sclerosis].
Topics: 4-Aminopyridine; Amantadine; Amifampridine; Benzhydryl Compounds; Fatigue; Humans; Hypnotics and Sedatives; Modafinil; Multiple Sclerosis; Severity of Illness Index; Surveys and Questionnaires | 2006 |